NASDAQ:RGC
Regencell Bioscience Holdings Limited
- Stock
Last Close
5.93
25/09 14:11
Market Cap
44.89M
Beta: -
Volume Today
11.69K
Avg: 926
PE Ratio
−17.51
PFCF: −20.60
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Jan '15 | Dec '15 | Dec '16 | Dec '17 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 18.40M - | 18.40M 0% | 20.10M 9.24% | 21.65M 7.71% | 21.90M 1.15% | 11.45M 47.72% | -13.80K - | ||||
average payables | 163.60M - | 167.95M 2.66% | 197.70M 17.71% | 212.25M 7.36% | 213.50M 0.59% | 116.10M 45.62% | |||||
average receivables | 116.85M - | 64.70M 44.63% | 76.55M 18.32% | 154.10M 101.31% | 169.55M 10.03% | 92M 45.74% | 42.07K - | ||||
book value per share | -4.61 - | -5.76 25.06% | -5.61 2.63% | -5.35 4.61% | -5.47 2.30% | -0.15 97.34% | -0.21 44.19% | -0.32 50.80% | 1.35 526.89% | 0.92 31.51% | |
capex per share | -0.72 - | -1.01 39.46% | -1.19 17.55% | -1.37 15.48% | -1.60 16.86% | -0.01 - | -0.06 - | -0.00 96.59% | |||
capex to depreciation | -0.55 - | -0.74 34.93% | -0.86 15.81% | -0.93 8.75% | -0.98 5.50% | -12.38 - | -1.29 - | -0.04 97.25% | |||
capex to operating cash flow | -0.32 - | -0.45 38.99% | -0.43 4.82% | -0.52 22.46% | -0.61 16.69% | 0.16 - | 0.15 - | 0.01 96.28% | |||
capex to revenue | -0.04 - | -0.05 42.12% | -0.06 13.24% | -0.07 13.20% | -0.08 17.78% | ||||||
cash per share | 1.86 - | 0.97 47.74% | 1.40 44.44% | 1.57 12.01% | 1.46 6.91% | 0.02 98.68% | 0.03 59.05% | 0.00 84.65% | 1.30 27,532.00% | 0.89 31.56% | |
days of inventory on hand | 62.48 - | 58.53 6.32% | 6.77 88.43% | 6.22 8.16% | 67.96 992.84% | ||||||
days payables outstanding | 559.67 - | 544.87 2.64% | 69.43 87.26% | 57.96 16.53% | 689.05 1,088.89% | ||||||
days sales outstanding | 15.55 - | 17.87 - | 17.71 0.91% | 21.23 19.91% | |||||||
debt to assets | 0.82 - | 0.89 8.81% | 0.86 3.94% | 0.84 1.97% | 0.83 0.93% | 8.56 928.10% | 5.97 30.20% | 10.83 81.25% | 0.04 99.60% | 0.04 14.17% | |
debt to equity | -3.11 - | -2.53 18.55% | -2.57 1.50% | -2.65 3.08% | -2.76 4.36% | -1.13 59.04% | -1.16 2.27% | -0.92 20.47% | 0.05 104.91% | 0.04 14.72% | |
dividend yield | 0.08 - | 0.18 122.33% | 0.08 53.17% | 0.08 0.36% | 0.08 0.29% | ||||||
earnings yield | 0.10 - | 0.06 33.24% | 0.09 44.18% | 0.10 10.84% | 0.07 33.91% | -0.00 104.31% | -0.01 107.77% | -0.01 65.78% | -0.02 67.26% | -0.02 15.40% | |
enterprise value | 3.56B - | 3.75B 5.24% | 3.68B 1.87% | 3.62B 1.54% | 3.78B 4.32% | 134.58M 96.44% | 135.43M 0.63% | 136.36M 0.69% | 431.77M 216.63% | 298.72M 30.82% | |
enterprise value over ebitda | 7.59 - | 9.59 26.28% | 7.82 18.41% | 7.07 9.61% | 8.06 14.02% | -344.20 4,369.39% | -168.68 50.99% | -100.65 40.33% | -61.56 38.83% | -54.27 11.84% | |
ev to operating cash flow | 10.27 - | 10.74 4.57% | 8.47 21.14% | 8.82 4.20% | 9.22 4.47% | -344.20 3,833.78% | -186.39 45.85% | -177.72 4.65% | -81.98 53.87% | -60.19 26.58% | |
ev to sales | 1.17 - | 1.25 6.93% | 1.18 6.17% | 1.13 3.69% | 1.19 5.44% | ||||||
free cash flow per share | 1.52 - | 1.24 18.34% | 1.59 28.36% | 1.25 21.52% | 1.02 18.22% | -0.03 103.03% | -0.07 115.97% | -0.06 9.13% | -0.48 688.20% | -0.38 19.84% | |
free cash flow yield | 0.14 - | 0.12 18.34% | 0.15 28.36% | 0.12 21.52% | 0.10 18.22% | -0.00 103.03% | -0.01 115.97% | -0.01 9.13% | -0.01 139.19% | -0.02 20.38% | |
graham net net | -19.53 - | -21.09 7.97% | -20.22 4.09% | -19.84 1.88% | -21.24 7.03% | -0.15 99.32% | -0.22 51.10% | -0.34 54.01% | 1.22 461.80% | 0.84 31.12% | |
graham number | 10.28 - | 9.39 8.63% | 11.13 18.49% | 11.44 2.83% | 9.41 17.77% | 0.32 96.62% | 0.55 73.08% | 0.87 58.11% | 4.22 385.06% | 3.06 27.46% | |
income quality | 2.20 - | 3.31 50.28% | 2.83 14.34% | 2.41 14.93% | 3.65 51.51% | 1 72.60% | 0.89 10.56% | 0.57 36.30% | 0.69 21.72% | 0.82 18.04% | |
intangibles to total assets | 0.14 - | 0.15 5.43% | 0.14 2.34% | 0.14 2.06% | 0.14 2.84% | 0 100% | 0 | 0 | 0 | 0 | |
interest coverage | 328.14 - | ||||||||||
interest debt per share | 14.32 - | 14.59 1.86% | 14.42 1.17% | 14.18 1.68% | 15.13 6.76% | 0.16 98.91% | 0.24 47.46% | 0.29 19.94% | 0.06 79.68% | 0.04 39.78% | |
inventory turnover | 5.84 - | 6.24 6.74% | 53.91 764.44% | 58.70 8.89% | 5.37 90.85% | ||||||
invested capital | -3.11 - | -2.53 18.55% | -2.57 1.50% | -2.65 3.08% | -2.76 4.36% | -1.13 59.04% | -1.16 2.27% | -0.92 20.47% | 0.05 104.91% | 0.04 14.72% | |
market cap | 1.63B - | 1.63B 0.30% | 1.64B 0.75% | 1.65B 0.21% | 1.64B 0.29% | 132.74M 91.91% | 132.74M 0% | 132.74M 0% | 437.42M 229.52% | 299.82M 31.46% | |
net current asset value | -2.95B - | -3.09B 4.74% | -3.07B 0.69% | -3.04B 1.11% | -3.24B 6.51% | -1.84M 99.94% | -2.78M 51.10% | -4.27M 53.74% | 15.51M 463.07% | 10.99M 29.13% | |
net debt to ebitda | 4.13 - | 5.42 31.26% | 4.33 20.09% | 3.86 10.90% | 4.56 18.21% | -4.70 203.12% | -3.34 28.93% | -2.67 19.99% | 0.80 130.11% | 0.20 75.15% | |
net income per share | 1.02 - | 0.68 33.24% | 0.98 44.18% | 1.09 10.84% | 0.72 33.91% | -0.03 104.31% | -0.06 107.77% | -0.11 65.78% | -0.59 451.16% | -0.45 23.16% | |
operating cash flow per share | 2.24 - | 2.25 0.34% | 2.78 23.51% | 2.62 5.70% | 2.62 0.14% | -0.03 101.18% | -0.06 85.83% | -0.06 5.61% | -0.42 586.43% | -0.38 8.46% | |
payables turnover | 0.65 - | 0.67 2.72% | 5.26 684.74% | 6.30 19.80% | 0.53 91.59% | ||||||
receivables turnover | 23.48 - | 20.43 - | 20.61 0.91% | 17.19 16.61% | |||||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | 0.07 - | 0.05 28.05% | 0.07 39.58% | 0.07 10.14% | 0.05 38.95% | -1.61 3,610.89% | -1.58 1.65% | -3.96 150.53% | -0.41 89.60% | -0.47 12.92% | |
revenue per share | 19.62 - | 19.26 1.87% | 19.99 3.81% | 20.39 2.01% | 20.23 0.78% | ||||||
roe | -0.22 - | -0.12 46.61% | -0.17 48.08% | -0.20 16.21% | -0.13 35.39% | 0.21 262.08% | 0.31 44.10% | 0.34 9.93% | -0.43 229.11% | -0.49 12.20% | |
roic | 0.13 - | 0.13 2.14% | 0.15 13.00% | 0.15 1.20% | 0.09 37.27% | -1.61 1,801.21% | -1.94 20.65% | 4.38 325.71% | -0.40 109.14% | -0.47 17.19% | |
sales general and administrative to revenue | 0.02 - | 0.02 2.57% | 0.16 542.94% | 0.16 0.14% | 0.03 82.91% | ||||||
shareholders equity per share | -4.61 - | -5.76 25.06% | -5.61 2.63% | -5.35 4.61% | -5.47 2.30% | -0.15 97.34% | -0.21 44.19% | -0.32 50.80% | 1.35 526.89% | 0.92 31.51% | |
stock based compensation to revenue | 0.00 - | 0.00 2.70% | 0.00 15.58% | 0.00 3.71% | 0.00 5.67% | ||||||
tangible asset value | -1.09B - | -1.27B 16.27% | -1.26B 0.99% | -1.21B 3.55% | -1.25B 2.75% | -1.84M 99.85% | -2.65M 44.19% | -4.00M 50.80% | 17.08M 527.27% | 11.99M 29.81% | |
tangible book value per share | -7.05 - | -8.17 15.93% | -8.03 1.73% | -7.73 3.76% | -7.96 3.05% | -0.15 98.17% | -0.21 44.19% | -0.32 50.80% | 1.35 527.27% | 0.92 31.81% | |
working capital | -41.30M - | -135.60M 228.33% | -113.10M 16.59% | -63.10M 44.21% | -98.10M 55.47% | -1.84M 98.13% | -2.78M 51.10% | -4.27M 53.74% | 15.87M 471.51% | 11.01M 30.58% |
All numbers in USD (except ratios and percentages)